WHO Admits to Releasing Pandemic Virus into Population via 'Mock-Up' Vaccines

[Guest guest]

http://articles.mercola.com/sites/articles/archive/2009/09/03/WHO-Admits-to-Rele\

asing-Pandemic-Virus-into-Population-via-MockUp-Vaccines.aspx

WHO Admits to Releasing Pandemic Virus into Population via 'Mock-Up' Vaccines

Posted by: Dr. Mercola

September 03 2009

The document on the WHO website linked below states that it is common procedure

to release pandemic viruses into the population in order to get a jump ahead of

the real pandemic, so as to fast track the vaccine for when it is needed.

In Europe, some manufacturers have conducted advance studies using a so-called

" mock-up " vaccine. Mock-up vaccines contain an active ingredient for an

influenza virus that has not circulated recently in human populations and thus

mimics the novelty of a pandemic virus.

According to the website, “Such advance studies can greatly expedite

regulatory approval.â€

Sources:

World Health Organization --

http://www.who.int/csr/disease/swineflu/notes/h1n1_safety_vaccines_20090805/en/i\

ndex.html

....STORY CONTINUES AT:

http://articles.mercola.com/sites/articles/archive/2009/09/03/WHO-Admits-to-Rele\

asing-Pandemic-Virus-into-Population-via-MockUp-Vaccines.aspx

--

[Guest guest]

http://articles.mercola.com/sites/articles/archive/2009/09/03/WHO-Admits-to-Rele\

asing-Pandemic-Virus-into-Population-via-MockUp-Vaccines.aspx

WHO Admits to Releasing Pandemic Virus into Population via 'Mock-Up' Vaccines

Posted by: Dr. Mercola

September 03 2009

The document on the WHO website linked below states that it is common procedure

to release pandemic viruses into the population in order to get a jump ahead of

the real pandemic, so as to fast track the vaccine for when it is needed.

In Europe, some manufacturers have conducted advance studies using a so-called

" mock-up " vaccine. Mock-up vaccines contain an active ingredient for an

influenza virus that has not circulated recently in human populations and thus

mimics the novelty of a pandemic virus.

According to the website, “Such advance studies can greatly expedite

regulatory approval.â€

Sources:

World Health Organization --

http://www.who.int/csr/disease/swineflu/notes/h1n1_safety_vaccines_20090805/en/i\

ndex.html

....STORY CONTINUES AT:

http://articles.mercola.com/sites/articles/archive/2009/09/03/WHO-Admits-to-Rele\

asing-Pandemic-Virus-into-Population-via-MockUp-Vaccines.aspx

--

[Guest guest]

http://articles.mercola.com/sites/articles/archive/2009/09/03/WHO-Admits-to-Rele\

asing-Pandemic-Virus-into-Population-via-MockUp-Vaccines.aspx

WHO Admits to Releasing Pandemic Virus into Population via 'Mock-Up' Vaccines

Posted by: Dr. Mercola

September 03 2009

The document on the WHO website linked below states that it is common procedure

to release pandemic viruses into the population in order to get a jump ahead of

the real pandemic, so as to fast track the vaccine for when it is needed.

In Europe, some manufacturers have conducted advance studies using a so-called

" mock-up " vaccine. Mock-up vaccines contain an active ingredient for an

influenza virus that has not circulated recently in human populations and thus

mimics the novelty of a pandemic virus.

According to the website, “Such advance studies can greatly expedite

regulatory approval.â€

Sources:

World Health Organization --

http://www.who.int/csr/disease/swineflu/notes/h1n1_safety_vaccines_20090805/en/i\

ndex.html

....STORY CONTINUES AT:

http://articles.mercola.com/sites/articles/archive/2009/09/03/WHO-Admits-to-Rele\

asing-Pandemic-Virus-into-Population-via-MockUp-Vaccines.aspx

--

[Guest guest]

http://articles.mercola.com/sites/articles/archive/2009/09/03/WHO-Admits-to-Rele\

asing-Pandemic-Virus-into-Population-via-MockUp-Vaccines.aspx

WHO Admits to Releasing Pandemic Virus into Population via 'Mock-Up' Vaccines

Posted by: Dr. Mercola

September 03 2009

The document on the WHO website linked below states that it is common procedure

to release pandemic viruses into the population in order to get a jump ahead of

the real pandemic, so as to fast track the vaccine for when it is needed.

In Europe, some manufacturers have conducted advance studies using a so-called

" mock-up " vaccine. Mock-up vaccines contain an active ingredient for an

influenza virus that has not circulated recently in human populations and thus

mimics the novelty of a pandemic virus.

According to the website, “Such advance studies can greatly expedite

regulatory approval.â€

Sources:

World Health Organization --

http://www.who.int/csr/disease/swineflu/notes/h1n1_safety_vaccines_20090805/en/i\

ndex.html

....STORY CONTINUES AT:

http://articles.mercola.com/sites/articles/archive/2009/09/03/WHO-Admits-to-Rele\

asing-Pandemic-Virus-into-Population-via-MockUp-Vaccines.aspx

--